Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micafungin pharmacokinetics with twice-weekly versus daily prophylactic dosing in high-risk hematology patients
NL-OMON57754Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of micafungin in invasive mycoses (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Micafungin pharmacokinetics. Started Nov 2014; status: completed.
02
Drugs
micafungin
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on NL-OMON57754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON57754.